Broaddus RR - Search Results

1

Context-dependent environmental associations with endometrial cancer histotype and genotype.

Nakad Borrego S, Kurnit K, Turner LJ, Broaddus RR. Nakad Borrego S, et al. Among authors: broaddus rr. Int J Gynecol Cancer. 2023 Aug 7;33(8):1215-1221. doi: 10.1136/ijgc-2023-004330. Int J Gynecol Cancer. 2023. PMID: 37380216 Free PMC article.

2

Low grade endometrioid endometrial cancer: complexities beyond p53abn.

Broaddus RR, Kurnit KC. Broaddus RR, et al. Int J Gynecol Cancer. 2021 Sep;31(9):1312. doi: 10.1136/ijgc-2021-002941. Epub 2021 Jul 28. Int J Gynecol Cancer. 2021. PMID: 34321288 Free PMC article. No abstract available.

3

Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival.

Kurnit KC, Fellman BM, Mills GB, Bowser JL, Xie S, Broaddus RR. Kurnit KC, et al. Among authors: broaddus rr. Int J Gynecol Cancer. 2022 Jul 4;32(7):869-874. doi: 10.1136/ijgc-2021-003340. Int J Gynecol Cancer. 2022. PMID: 35483739 Free PMC article.

4

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.

Kurnit KC, Kim GN, Fellman BM, Urbauer DL, Mills GB, Zhang W, Broaddus RR. Kurnit KC, et al. Among authors: broaddus rr. Mod Pathol. 2017 Jul;30(7):1032-1041. doi: 10.1038/modpathol.2017.15. Epub 2017 Mar 10. Mod Pathol. 2017. PMID: 28281553 Free PMC article.

5

Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer.

Kurnit KC, Draisey A, Kazen RC, Chung C, Phan LH, Harvey JB, Feng J, Xie S, Broaddus RR, Bowser JL. Kurnit KC, et al. Among authors: broaddus rr. Cancer Lett. 2021 May 1;505:75-86. doi: 10.1016/j.canlet.2021.01.030. Epub 2021 Feb 17. Cancer Lett. 2021. PMID: 33609609 Free PMC article.

6

Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.

Kim G, Kurnit KC, Djordjevic B, Singh C, Munsell MF, Wang WL, Lazar AJ, Zhang W, Broaddus R. Kim G, et al. Mod Pathol. 2018 Oct;31(10):1553-1559. doi: 10.1038/s41379-018-0080-0. Epub 2018 May 24. Mod Pathol. 2018. PMID: 29795437 Free PMC article.

7

Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes.

Crumley S, Kurnit K, Hudgens C, Fellman B, Tetzlaff MT, Broaddus R. Crumley S, et al. Mod Pathol. 2019 Mar;32(3):396-404. doi: 10.1038/s41379-018-0148-x. Epub 2018 Oct 5. Mod Pathol. 2019. PMID: 30291344 Free PMC article.

8

The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.

Meyer LA, Slomovitz BM, Djordjevic B, Westin SN, Iglesias DA, Munsell MF, Jiang Y, Schmandt R, Broaddus RR, Coleman RL, Galbincea JM, Lu KH. Meyer LA, et al. Among authors: broaddus rr. Int J Gynecol Cancer. 2014 May;24(4):713-7. doi: 10.1097/IGC.0000000000000118. Int J Gynecol Cancer. 2014. PMID: 24651628 Free PMC article. Clinical Trial.

9

Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.

Gan Q, Crumley S, Broaddus RR. Gan Q, et al. Among authors: broaddus rr. Int J Gynecol Pathol. 2019 Jan;38(1):44-51. doi: 10.1097/PGP.0000000000000465. Int J Gynecol Pathol. 2019. PMID: 29210800 Free PMC article.

10

Clinicopathological features in endometrial carcinoma associated with Lynch syndrome in China.

Wang Y, Xue F, Broaddus RR, Tao X, Xie SS, Zhu Y. Wang Y, et al. Among authors: broaddus rr. Int J Gynecol Cancer. 2009 May;19(4):651-6. doi: 10.1111/IGC.0b013e3181a12fb9. Int J Gynecol Cancer. 2009. PMID: 19509565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters